Prof. Ayman Said Emam Desoky El-Habbaa :: Publications:

An inactivated oil-emulsion H5N1 avian influenza (AI) vaccine was experimentally formulated with 3 parts of an inactivated avian influenza virus [A/chicken/Egypt/Q1995D/2010 strain-1 and A/duck/Egypt/M2583A/2010 strain-2] emulsified in 7 parts of oil adjuvant. The prepared vaccine was sterile and safe. This water in oil (W/O) emulsion showed zero mS/cm conductivity and 22.67 m.pa.s viscosity; this low viscosity reflected on easy injection of the vaccine emulsion. In addition, long duration of stability for 24 months at +4C°. Cell mediated immune response of chicks vaccinated at 21 days age were assessed using lymphocyte blastogenesis and phagocytic activity showed high values from the 3rd day post vaccination (DPV) and continued till 21st DPV. Serum antibody titer against avian influenza virus (AIV) H5N1 was increased from the 1st week post vaccination (WPV) and persisted in high values till 31st WPV using hemagglutination inhibition (HI) test. Efficacy of the prepared vaccine showed 100% protection in challenged vaccinated chicks. In conclusion, the prepared AI subtype H5N1 vaccine on Montanide ISA-71 showed good humoral and cellular immune responses that could cover two varieties of H5N1 subtypes circulating in Egypt.